Trials / Unknown
UnknownNCT04916834
Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.
Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure - Prospective Case Control Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- National Institute for Tuberculosis and Lung Diseases, Poland · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Prospective study in a group of patients with COVID-19 pneumonia.
Detailed description
Objective: Assessment of pulmonary and heart dysfunction, fibrosis-related markers and antibodies as well as the search for risk factors for an unfavorable course and possible complications in patients after pneumonia due to SARS-CoV-2 (COVID-19) infection. Patients: A group of approx. 100 patients assessed shortly after pneumonia and followed up, investigated after 3 and 6 months with possible prolongation to 12 months.
Conditions
Timeline
- Start date
- 2020-08-30
- Primary completion
- 2023-11-30
- Completion
- 2024-11-30
- First posted
- 2021-06-08
- Last updated
- 2023-02-23
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04916834. Inclusion in this directory is not an endorsement.